## Abstract ## BACKGROUND Contralateral, metachronous upper urinary tract (UUT) tumors after primary transitional cell carcinoma (TCC) of the UUT are reported rarely, and to the authors' knowledge the risk factors have not been determined to date. In addition, few reports have described the charac
Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival
β Scribed by Bogomir Milojevic; Milan Djokic; Sandra Sipetic-Grujicic; Dragica Milenkovic-Petronic; Aleksandar Vuksanovic; Dejan Dragicevic; Uros Bumbasirevic; Cane Tulic
- Publisher
- Springer Netherlands
- Year
- 2011
- Tongue
- English
- Weight
- 255 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sixty-nine patients who underwent nephroureterectomy for upper urinary tract transitional cell carcinoma were included in the study. The following data were collected for each patient: grade and stage of renalhreteral tumor, tumor location, timing of tumor appearance and recurrence in the bladder, g
## Abstract ## BACKGROUND: The authors evaluated the incidence of pathologic downstaging and complete remission (CR) in patients with highβgrade ureteral and renal pelvic transitional cell carcinoma (TCC) (upper tract TCC) who received neoadjuvant chemotherapy followed by surgery. ## METHODS: Th
## Abstract ## BACKGROUND. The objective of the current study was to identify variables that were predictive of cancerβspecific survival in patients with nonmetastatic transitional cell carcinoma of the upper urinary tract (UUTβTCC). ## METHODS. Clinical and pathologic data from 269 patients who